Meanwhile, transforming growth factor beta (TGF-β) receptor type 1 (TGFBR1) and TGFBR2 gene alterations are linked to patent ductus arteriosus (Nicoll, 2018). This evidence concerns the gene TGFBR2 and Patent ductus arteriosus.